Guided Therapeutics Inc (GTHP): Capital Expenditures

Annual figures by period end, from SEC filings.

$2.0K
Year ended 2025-12-31
-59.9%
3-year compound annual growth
+14.9%
5-year compound annual growth
$31.0K2019-12-31: $02020-12-31: $1.0K2021-12-31: $14.0K2022-12-31: $31.0K2023-12-31: $02024-12-31: $02025-12-31: $2.0K$2.0K
2019-12-31 Capital Expenditures (USD) 2025-12-31
Period endedCapital ExpendituresChange YoYSource filing
2025-12-31$2.0Kn/a2026-03-31, From 2025-01-01
2024-12-31$0n/a2026-03-31, From 2024-01-01
2023-12-31$0-100.0%2024-03-28, From 2023-01-01
2022-12-31$31.0K+121.4%2024-03-28, From 2022-01-01
2021-12-31$14.0Kn/m2023-03-30, From 2021-01-01
2020-12-31$1.0Kn/a2022-03-30, From 2020-01-01
2019-12-31$0n/a2021-04-07, From 2019-01-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Electromedical & Electrotherapeutic Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
Guided Therapeutics Inc (GTHP)2025-12-31$2.0Kn/a
iTonic Holdings Ltd (ITOC)2025-12-31$3.8K+342.0%
Hongchang International Co., Ltd (HCIL)2024-12-31$4.02M-90.1%
Neuraxis, Inc (NRXS)2025-12-31$31.1K+12.1%
Nuwellis, Inc. (NUWE)2025-12-31$90.0K+50.0%
Escalon Medical Corp (ESMC)2026-06-30$4.4K+13.9%
CapsoVision, Inc (CV)2025-12-31$90.0K-41.2%
Hyperfine, Inc. (HYPR)2025-12-31$1.19M+209.4%
QT Imaging Holdings, Inc. (QTI)2025-12-31$124.0K+40.9%

Compare GTHP, ITOC, HCIL, NRXS side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗